Apricus Biosciences
- Pharmaceutical Preparations
- New York, New York
Compensation history
Top executives at Apricus Biosciences received an average of $2M per person in annual compensation from 2010 to 2023.
Average pay of disclosed executives at Apricus Biosciences
By year
Executives
We found eight executives who work or worked at Apricus Biosciences.
Raj Mehra
Apricus Biosciences
Chief Executive Officer
Michael Golembiewski
Apricus Biosciences
Chief Financial Officer
Richard Pascoe
Apricus Biosciences
Chief Executive Officer
Neil Morton
Apricus Biosciences
Former Senior Vice President, Chief Business Officer
Steve Martin
Apricus Biosciences
Chief Financial Officer
Randy Berholtz
Apricus Biosciences
General Counsel
Edward Cox
Apricus Biosciences
Vice President of Commercial Development
Bassam Damaj
Apricus Biosciences
Chief Executive Officer
News
Apricus Biosciences CEO Raj Mehra's 2023 pay falls 30% to $1.7M
August 20, 2024
Apricus Biosciences CEO Raj Mehra's 2022 pay falls 84% to $2.5M
April 12, 2023
Apricus Biosciences CEO Raj Mehra's 2021 pay jumps 270% to $16M
April 12, 2022
Apricus Biosciences CEO Richard Pascoe's 2019 pay rises 15% to $1.2M
April 13, 2020
About Apricus Biosciences
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryPharmaceutical Preparations
- Address300 Park Avenue, 2nd Floor, New York, New York 10022
- Phone(646) 293-2100
- Fiscal year endDecember 31
- Former names
- APRICUS BIOSCIENCES, INC.Until January 23, 2019
- NEXMED INCUntil September 12, 2010
Source: SEC filings on August 20, 2024, April 12, 2023, April 12, 2022, April 13, 2020, April 8, 2014, and April 8, 2013.